ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma

Leukemia

Volumn 22, Issue 10, 2008, Pages 1942-1944

  Ushmorov, A ^a   Leithauser F ^a   Ritz, O ^a   Barth, T F E ^a   Moller P ^a   Wirth, T ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED B CELL FACTOR 1; MESSENGER RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CASE REPORT; CELL SPECIFICITY; CONTROLLED STUDY; CPG ISLAND; EPIGENETICS; FOLLICULAR LYMPHOMA; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LARGE CELL LYMPHOMA; LYMPHOID HYPERPLASIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METHYLATION;

EID: 54049146701     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.70     Document Type: Article

References (8)

1. Massari ME, Rivera RR, Voland JR, Quong MW, Breit TM, van Dongen JJ et al. Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol Cell Biol 1998; 18: 3130-3139.
2. Zhao F, Vilardi A, Neely RJ, Choi JK. Promotion of cell cycle progression by basic helix-loop-helix E2A. Mol Cell Biol 2001; 21: 6346-6357.
3. Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, Lusatis S et al Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 2006; 7: 207-215.
4. Renne C, Martin-Subero JI, Eickernjager M, Hansmann ML, Kuppers R, Siebert R et al. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. Am J Pathol 2006; 169: 655-664.
5. Kuppers R, Klein U, Schwering I, Distler V, Brauninger A, Cattoretti G et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 2003; 111: 529-537.
6. Lietz A, Janz M, Sigvardsson M, Jundt F, Dorken B, Mathas S. Loss of bHLH transcription factor E2A activity in primary effusion lymphoma, confers resistance to apoptosis. Br J Haematol 2007; 137: 342-348.
7. Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci 2005; 96: 206-211.
8. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD et al Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198: 851-862.